M1A.2491 Drug-induced chronic gout, unspecified hand, with tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Unspecified Hand, with Tophus (tophi)

Summary

Drug-induced chronic gout, unspecified hand, with tophus (tophi) is a form of arthritis affecting the hand joints, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and the presence of tophi (urate crystal deposits) in the hand.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the hand joints and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense hand joint pain, often with swelling and redness
• Persistent warmth and tenderness in the affected hand joints
• Formation of tophi (hard, painless lumps) around the hand joints
• Stiffness and limited range of motion in the hand
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging studies to confirm urate crystal deposits. A thorough medication history is critical to identify the drug-induced cause. Synovial fluid analysis may reveal monosodium urate crystals, and imaging (e.g., X-rays) can show joint damage or tophi.

Treatment Options

Treatment focuses on managing uric acid levels and reducing inflammation. This may include discontinuing the causative medication, if possible, and initiating urate-lowering therapy (e.g., allopurinol, febuxostat). Anti-inflammatory medications (e.g., NSAIDs, colchicine) can alleviate acute symptoms. In some cases, local treatment for tophi (e.g., aspiration or surgery) may be considered.

Prognosis and Follow-Up

With appropriate management, symptoms can be controlled, and further joint damage may be prevented. Regular follow-up is essential to monitor uric acid levels and adjust treatment. Tophi may persist but typically do not resolve without specific intervention.

Complications

Untreated or poorly managed cases can lead to chronic joint damage, deformity, and persistent pain. Tophi may ulcerate or become infected. Long-term inflammation can also contribute to kidney issues or cardiovascular risks associated with gout.

Lifestyle & Prevention

• Avoid medications known to raise uric acid levels when possible.
• Maintain a balanced diet low in purines (e.g., limit red meat, seafood, and alcohol).
• Stay hydrated to support uric acid excretion.
• Follow prescribed urate-lowering therapy consistently.

When to Seek Professional Help

Seek care if you experience sudden, severe hand pain, swelling, or redness, or if tophi develop or change. Prompt evaluation is important if symptoms worsen or do not improve with initial treatment.

Tips for Medical Coders

Document the presence of tophi and the unspecified hand location clearly. Ensure the causative drug relationship is supported by clinical findings or medication history. Code M1A.2491 is specific to drug-induced chronic gout with tophi in the unspecified hand; verify no more precise hand location is documented before using this code.